Magnesium Glycinate vs. Magnesium L-Threonate

A magnesium supplement does not contain free magnesium metal. It contains magnesium associated with another substance that makes a stable, usable compound. In magnesium glycinate, magnesium is chelated with glycine. In magnesium L-threonate, it is associated with L-threonic acid, a metabolite related to vitamin C metabolism.

Both forms follow the same basic route: they are swallowed, encounter the digestive tract, are absorbed into the bloodstream and then enter the body's regulated magnesium economy. L-threonate does not have a separate path from the stomach directly to the brain. The scientific question begins after absorption: whether the carrier changes magnesium distribution or retention in ways that matter for a particular outcome.

Carriers can influence how readily a compound dissolves, how comfortably it is tolerated, how much elemental magnesium fits into a serving and why the form is included in a particular formula. They should not be treated as proof that an intact supplement molecule reaches a particular tissue.

Once magnesium is absorbed, the body regulates and uses magnesium ions across hundreds of biochemical processes, including normal nerve and muscle function, cellular energy production, protein synthesis, electrolyte transport and normal heart rhythm. The carrier matters, but it does not change the identity of the essential mineral being supplied.

The familiar phrase compresses several different findings into one marketable sentence. In a foundational 2010 study, researchers screened multiple magnesium compounds in rats, including glycinate, and selected L-threonate after it produced a greater increase in cerebrospinal-fluid magnesium under those experimental conditions. Longer oral treatment increased brain magnesium and was associated with changes in synaptic plasticity, learning and memory. That is meaningful preclinical evidence—but it is still animal evidence.

A later mechanistic study found that oral L-threonate raised threonate in rat cerebrospinal fluid and that threonate affected intracellular magnesium through glucose transporters in cultured neurons. This is the basis for some transporter claims. It does not demonstrate that intact magnesium L-threonate is a fat-soluble “Trojan horse,” that it hijacks glucose transporters at the human blood-brain barrier, or that the complete compound crosses into the human brain unchanged.

Human trials have reported some positive cognitive outcomes. A 12-week randomized, placebo-controlled trial in adults ages 50 to 70 used 1.5–2 grams per day and reported improvement in a composite cognitive score. The analysis included only 44 participants, the work was supported by the company developing the compound, and magnesium was measured in plasma, urine and red blood cells—not in brain tissue or cerebrospinal fluid.

A newer six-week randomized trial provided 2 grams of Magtein®, equal to 145 mg of elemental magnesium, to 100 adults ages 18 to 45. The primary composite cognition score and some individual outcomes favored Magtein, while a separate test of fluid intelligence did not. One subjective sleep measure improved, but other subjective measures and the sleep outcomes recorded by an Oura Ring did not differ from placebo. ThreoTech funded the study, supplied the product and intellectual property, and participated in study conceptualization.

The factual conclusion is narrower than the advertising claim: magnesium L-threonate increased brain magnesium in animals and has produced some promising human cognitive results. It has not been shown to be the only magnesium source the human brain can use, and human trials have not directly established that intact magnesium L-threonate crosses the human blood-brain barrier.

After an absorbable magnesium compound is digested, magnesium becomes available to the body's regulated magnesium pool. Magnesium ions can then be transported into the brain through the blood-brain and blood-cerebrospinal-fluid barriers.

It is not correct that every bit of magnesium consumed eventually reaches the brain. Not all magnesium is absorbed, and absorbed magnesium is distributed throughout bone, muscle and other soft tissues according to physiological need. The brain receives a carefully regulated portion.

It is equally incorrect to suggest that magnesium from glycinate, food or other absorbable sources remains outside the brain indefinitely. The glycine carrier does not have to transport the entire compound intact across the barrier for magnesium glycinate to support the body's magnesium supply and normal nervous-system function.

Magnesium glycinate contributes to the body's usable magnesium supply, which supports normal nervous-system function through this established physiology. Nothing in the available evidence shows that the brain can use magnesium supplied by L-threonate but not magnesium supplied by a well-absorbed form such as glycinate. What remains unproven is the marketing implication that L-threonate has exclusive access to the human brain.

Glycine is an amino acid used throughout the body. In the nervous system, it acts as an inhibitory neurotransmitter in some regions and as a co-agonist at NMDA receptors involved in normal neuronal communication.

This biology gives glycinate a coherent advantage for an evening formula: it pairs magnesium's established role in normal nerve and muscle function with an amino-acid carrier naturally involved in inhibitory signaling and normal neuronal communication. The result is a purposeful chelate that aligns naturally with relaxation and nighttime use.

Human research has also evaluated magnesium bisglycinate directly. In a 2025 randomized, double-blind, placebo-controlled trial, 155 adults reporting poor sleep received either placebo or magnesium bisglycinate providing 250 mg of elemental magnesium per day. After four weeks, the magnesium bisglycinate group had a significantly greater reduction in insomnia-severity scores than the placebo group.

This study provides direct human evidence relevant to glycinate's intended evening use. Its design and outcome are closely aligned with the reason people choose glycinate: to combine meaningful magnesium support with a form suited to a calm nighttime routine.

Magnesium L-threonate is a rational option for someone specifically seeking a patented, cognition-positioned magnesium ingredient. Its animal research and emerging human cognitive findings distinguish it from ordinary commodity forms. The evidence is interesting enough to justify further study, but not strong enough to treat every marketing claim as settled fact.

“Brain-focused” should not be interpreted as “the only magnesium the brain can use.” Magnesium from the bloodstream is actively transported into the brain. Glycinate supplies magnesium through a well-absorbed organic amino-acid chelate, provides a higher elemental yield and has a favorable digestive profile. Systematic evidence generally favors organic over inorganic magnesium formulations, strengthening glycinate's position as a practical form for restoring and maintaining magnesium levels.

There is no human head-to-head trial demonstrating that L-threonate is superior to glycinate for cognition, relaxation, sleep support or general magnesium replenishment. For cognition, L-threonate has more form-specific research; for evening use and practical magnesium delivery, glycinate has advantages that are directly relevant and do not depend on a blood-brain-barrier marketing claim.

Magnesium Glycinate Sleep Stack is not intended to be a single-ingredient cognition product. It is a focused evening formula designed to support relaxation and restful sleep while helping to restore and maintain your body's optimal level of magnesium.

Each two-capsule serving provides 1,250 mg magnesium glycinate, 175 mg elemental magnesium, 200 mg L-theanine and 50 mg apigenin.

Magnesium glycinate supplies the foundational mineral in a well-absorbed, generally gentle form. L-theanine is included to support relaxation and a calm state of mind, while apigenin, a naturally occurring flavonoid associated with chamomile, complements the formula's nighttime focus.

The strategy is not to make glycinate behave exactly like L-threonate. It is to combine meaningful elemental magnesium, an evening-aligned carrier and two complementary ingredients in clearly stated quantities.

Compare magnesium glycinate with oxide, citrate and other forms →

Understand the magnesium glycinate, L-theanine and apigenin sleep stack →